Par Pharmaceuticals Private Limited

Par Pharmaceuticals Private Limited - pharma in Muzaffarnagar, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24232UP1998PTC023818 Incorporated 02 September 1998 ROC Kanpur HQ Muzaffarnagar, Uttar Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹3.13 Cr
▲ 3% YoY
Net profit · FY 2025
₹37,227
Net margin 0.1%
EBITDA · FY 2025
₹32.43 Lakh
EBITDA margin 10.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹10.65 Lakh
Issued & subscribed
Satisfied charges
₹12 Lakh
No open charges
Company age
28 yrs
Est. 1998
Directors on board
3
As per MCA filings

About Par Pharmaceuticals Private Limited

Data last updated:

Par Pharmaceuticals Private Limited is a private limited company based in Muzaffarnagar, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 September 1998 and has been in existence for over 28 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24232UP1998PTC023818. Its GSTIN is 09AACCP2319Q1Z0 (Uttar Pradesh).

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10.65 Lakh. It is led by directors including Anju Goel (Managing Director) and Abhishek Goel.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 5 Km Roorkee Road, Muzaffarnagar, Uttar Pradesh, India – 251001.

As per the financials filed for FY 2025, the company reported a revenue of ₹3.13 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹37,227 (net margin 0.1%) and EBITDA of ₹32.43 Lakh (EBITDA margin 10.4%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 3% over five years.

As per MCA filings, the company has satisfied charges of ₹12 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Par Pharmaceuticals Private Limited
CIN U24232UP1998PTC023818
Registration Number 023818
Incorporation Date 02 September 1998
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    5 Km Roorkee Road, Muzaffarnagar, Uttar Pradesh, India – 251001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Par Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Par Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Par Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Par Pharmaceuticals Private Limited

The main business activity of Par Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Par Pharmaceuticals Private Limited FY 2024 filings available

Par Pharmaceuticals Private Limited reported revenue of ₹3.13 Cr (up 3% YoY) for FY 2025.

Revenue · FY 2025
₹3.13 Cr ▲ 3%
Net profit · FY 2025
₹37,227 margin 0.1%
EBITDA · FY 2025
₹32.43 Lakh margin 10.4%

Compounded Annual Growth Rate (CAGR) of Par Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▼ 5%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▲ 134%
3 years · compounded
▲ 30%
5 years · compounded
▲ 5%

Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 134% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Par Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹32.43 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹37,227••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Par Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin10.4%••••••••••••••••
Net Profit Margin0.1%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Par Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Par Pharmaceuticals Private Limited

Par Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Zest Diabetes Care Private Limited₹3.13 Cr (FY 2025)••••••••7.0%••••Andheri(West) Mumbai, Maharashtra, India
Kumudham Pharmacy Private Limited₹3.13 Cr (FY 2018)••••••••-27.0%••••Coimbatore, Tamil Nadu, India
Prospero Pharmaceuticals Pvt Ltd₹3.13 Cr (FY 2025)••••••••-11.0%••••Kolkata, West Bengal, India
Sanvariya Pharmaceuticals Private Limited₹3.13 Cr (FY 2025)••••••••20.0%••••Jalore, Rajasthan, India
Parth Antibiotics Private Limited₹3.13 Cr (FY 2020)••••••••64.0%••••Mumbai, Maharashtra, India
Par Pharmaceuticals Private Limited this company₹3.13 Cr (FY 2025)••••••••3.0%••••Muzaffarnagar, Uttar Pradesh, India
Beauty Beyond Borders Private Limited₹3.13 Cr (FY 2025)••••••••••••Bangalore, Karnataka, India
Patwa Pharmaceuticals Private Limited₹3.13 Cr (FY 2025)••••••••1617.0%••••Gujarat, India
Eusalus Life Science Private Limited₹3.13 Cr (FY 2024)••••••••45.0%••••New Delhi, Delhi, India
Benzorgo Health Care Private Limited₹3.13 Cr (FY 2025)••••••••-51.0%••••Mumbai, Maharashtra, India
Zaq Health Care Private Limited₹3.12 Cr (FY 2025)••••••••42.0%••••Mumbai, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Par Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Par Pharmaceuticals Private Limited

Par Pharmaceuticals Private Limited is audited by M/s Goel Rakesh & Co. for the financial year 2024.

NameStatusAppointment DateCessation Date
M/s Goel Rakesh & Co.LockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Par Pharmaceuticals Private Limited

Par Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Abhishek GoelDirector16 Jul 200818 Years 2 MonthsCurrent
Dinesh Kumar GoelDirector01 Apr 200224 Years 6 MonthsCurrent
Anju GoelManaging Director01 Apr 200224 Years 6 MonthsCurrent

Ownership and Shareholding of Par Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Par Pharmaceuticals Private Limited

Open charges
None
Satisfied charges
₹12 Lakh
Breakdown by lending institutions
State Bank of Patiala₹0.12 Cr
Latest charge details
DateLenderAmountStatus
20 Feb 2015State Bank of Patiala₹12 LakhSatisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Par Pharmaceuticals Private Limited

Par Pharmaceuticals Private Limited has a workforce of 0 employees as of Mar 11, 2025.

Active EPFO establishments
1
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Par Pharmaceuticals Private Limited

Par Pharmaceuticals Private Limited has 3 board changes on record since 2002: 3 appointments. The latest: Abhishek Goel was appointed as Director on 16 Jul 2008.

AGM
Par Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Par Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
Charges
A charge registered on 20 Feb 2015 via Charge ID 10552429 with State Bank Of Patiala was fully satisfied on 26 Jun 2022.
Charges
A charge with State Bank Of Patiala amounted to Rs. 12.00 Lakh with Charge ID 10552429 was registered on 20 Feb 2015.
Appointed
Abhishek Goel was appointed as Director.
Appointed
Anju Goel was appointed as Managing Director.
Appointed
Dinesh Kumar Goel was appointed as Director.
Incorporation
02 Sep 1998
Par Pharmaceuticals Private Limited was registered on 02 Sep 1998 with Roc Kanpur & aged 28 years 1 month as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Par Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Par Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Par Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Par Pharmaceuticals Private Limited

Par Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AACCP2319Q1Z0Uttar PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Par Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Par Pharmaceuticals Private Limited

Par Pharmaceuticals is an active private limited company based in Muzaffarnagar, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 September 1998 (28+ years old) and is registered under CIN U24232UP1998PTC023818.

Par Pharmaceuticals reported revenue of ₹3.13 Cr for FY 2025 (up 3% YoY).

Par Pharmaceuticals has 3 current directors:

Par Pharmaceuticals reported a net profit of ₹37,227 (net margin 0.1%) and EBITDA of ₹32.43 Lakh (EBITDA margin 10.4%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Par Pharmaceuticals is -5% over three years and -3% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Par Pharmaceuticals is 09AACCP2319Q1Z0, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Par Pharmaceuticals is U24232UP1998PTC023818. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Par Pharmaceuticals was incorporated on 02 September 1998, making it 28+ years old. It is registered with the Registrar of Companies, Kanpur.

The peers of Par Pharmaceuticals by revenue are Zest Diabetes Care Private Limited, Kumudham Pharmacy Private Limited, Prospero Pharmaceuticals Pvt Ltd, Sanvariya Pharmaceuticals Private Limited, Parth Antibiotics Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).

Abhishek Goel was appointed as Director on 16 Jul 2008. Anju Goel was appointed as Managing Director on 01 Apr 2002. Dinesh Kumar Goel was appointed as Director on 01 Apr 2002.

The registered office of Par Pharmaceuticals is at 5 Km Roorkee Road, Muzaffarnagar, Uttar Pradesh, India – 251001.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available